The “Shield” Is Gone For years, the Johnson & Johnson talc lawsuit was defined by a single stalling tactic: the “Texas Two-Step” bankruptcy maneuver. That era is officially over. The rejection of J&J’s third bankruptcy attempt in early...
Introduction: The Litigation That Won’t Go Away For many firms, the hernia mesh lawsuit landscape feels like “old news.” With major recalls dating back to 2010 (Ethicon Physiomesh) and 2016 (Atrium C-Qur), it is easy to assume the window has closed....
The New Litigation Landscape For months, the legal industry treated NEC (Necrotizing Enterocolitis) cases as a secondary focus. That changed this December. On December 17, 2025, a Connecticut jury awarded $32 million to the family of a premature infant who died after...
A Tale of Two Injuries For the past two years, “Ozempic litigation” was synonymous with stomach paralysis. But as we enter 2026, the smart money has moved. On December 15, 2025, the Judicial Panel on Multidistrict Litigation (JPML) officially approved the...
A Major Shift in the Depo-Provera Landscape If you’ve been watching the Depo-Provera litigation from the sidelines, it’s time to get in the game. For decades, the birth control shot was marketed as a convenient alternative to the pill, but as of December 2025, the...
